Research work · 2016

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp

The Lancet

Download PDF

DOI: 10.1016/s0140-6736(16)32517-x